We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Top Buys

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$55.3M
2
AAPL icon
Apple
AAPL
+$33.2M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
MSFT icon
Microsoft
MSFT
+$26.4M
5
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$22.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$93.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$51.5M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCNCA icon
3601
First Citizens BancShares
FCNCA
$25.2B
$23K ﹤0.01%
57
-45
-44% -$16.5K
FNF icon
3602
Fidelity National Financial
FNF
$12.8B
$23K ﹤0.01%
776
-63,854
-99% -$1.76M
HBIO icon
3603
Harvard Bioscience
HBIO
$28M
$23K ﹤0.01%
741
+731
+7,310% +$19.7K
LEE icon
3604
Lee Enterprises
LEE
$183M
$23K ﹤0.01%
+2,304
New +$22K
MIRM icon
3605
Mirum Pharmaceuticals
MIRM
$6.1B
$23K ﹤0.01%
+1,160
New +$19.4K
ONEW icon
3606
OneWater Marine
ONEW
$212M
$23K ﹤0.01%
+946
New +$13.4K
RMNI icon
3607
Rimini Street
RMNI
$449M
$23K ﹤0.01%
+4,446
New +$18.9K
VTVT icon
3608
vTv Therapeutics
VTVT
$135M
$23K ﹤0.01%
+259
New +$25.6K
ZEUS
3609
DELISTED
Olympic Steel
ZEUS
$23K ﹤0.01%
+1,949
New +$19.3K
VIVS
3610
VivoSim Labs
VIVS
$1.28M
$23K ﹤0.01%
+171
New +$20.8K
CVLY
3611
DELISTED
Codorus Valley Bancorp Inc
CVLY
$23K ﹤0.01%
+1,670
New +$22.3K
RTLR
3612
DELISTED
Rattler Midstream LP Common Units
RTLR
$23K ﹤0.01%
2,328
+1,367
+142% +$10.6K
SCVX
3613
DELISTED
SCVX Corp.
SCVX
$23K ﹤0.01%
+2,339
New +$22.9K
FCCY
3614
DELISTED
1st Constitution Bancorp
FCCY
$23K ﹤0.01%
1,886
+1,751
+1,297% +$21.5K
ZAGG
3615
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$23K ﹤0.01%
7,395
-1,614
-18% -$5.07K
SRAX
3616
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$23K ﹤0.01%
+9,137
New +$17.9K
REV
3617
DELISTED
Revlon, Inc.
REV
$23K ﹤0.01%
+2,367
New +$25.9K
ACNT icon
3618
Ascent Industries
ACNT
$141M
$22K ﹤0.01%
+2,932
New +$25.5K
AFYA icon
3619
Afya
AFYA
$1.22B
$22K ﹤0.01%
936
-2,577
-73% -$52.9K
AUPH icon
3620
Aurinia Pharmaceuticals
AUPH
$2.04B
$22K ﹤0.01%
+1,376
New +$22K
BBAR icon
3621
BBVA Argentina
BBAR
$3.52B
$22K ﹤0.01%
+5,754
New +$18.8K
BTU icon
3622
Peabody Energy
BTU
$2.99B
$22K ﹤0.01%
7,479
+7,419
+12,365% +$24.5K
CCO icon
3623
Clear Channel Outdoor Holdings
CCO
$1.23B
$22K ﹤0.01%
+21,138
New +$19.9K
ELVN icon
3624
Enliven Therapeutics
ELVN
$4.23B
$22K ﹤0.01%
+200
New +$22.4K
EXAS
3625
DELISTED
Exact Sciences
EXAS
$22K ﹤0.01%
+252
New +$20.1K
143 144
145
146 147

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.